Steven Dill, MD
Radiation Oncology · Knoxville, TNNPI 1770732836
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $1,102 of the $1,812 with a category attached, or 60.8%. Varian Medical Systems, Inc. accounts for 65.5% of it on its own, with 17 other manufacturers making up the rest. Reporting peaked in 2019 at $1,302 and has fallen 79.7% since, to $265 in 2025.
Across 32 payments — averaging $56.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Varian Medical Systems, Inc.$1K
- Teleflex LLC$142
- AstraZeneca$82
- Merck$52
- Novocure Inc.$52
- Siemens Medical Solutions USA, Inc.$45
- plus $253 from 12 others
What the payments were for
- Travel & lodging$1,10261%
- Food & beverage$71039%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Varian Medical Systems, Inc. | 5 | $1,187 |
| Teleflex LLC | 1 | $142 |
| AstraZeneca(2 entities) | 4 | $82 |
| Merck | 3 | $52 |
| Novocure Inc. | 3 | $52 |
| Siemens Medical Solutions USA, Inc. | 2 | $45 |
| Bayer | 2 | $36 |
| Regeneron Healthcare Solutions, Inc. | 1 | $33 |
| Boehringer Ingelheim | 2 | $30 |
| Myriad Genetic Laboratories, Inc. | 1 | $25 |
| Boston Scientific | 1 | $20 |
| Eisai Inc. | 1 | $19 |
| Novartis | 1 | $18 |
| Ferring Pharmaceuticals Inc. | 1 | $17 |
| Genentech USA, Inc. | 1 | $17 |
| Foundation Medicine, Inc. | 1 | $14 |
| Amgen | 1 | $13 |
| Seagen Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,812 in reported general payments places this provider in the 70th percentile of 115 radiation oncology providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dexamethasone | 20 | $389 |
| Silver Sulfadiazine | 11 | $159 |
| Ciprofloxacin Hcl | 12 | $90 |
| Omeprazole | 11 | $42 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Knoxville
- Nilesh PatelKnoxville$2K
- Lee CarderKnoxville$1K
- Srinivas BoppanaKnoxville$990
- Nevine HannaKnoxville$775
- Marc AppleKnoxville$622
- Han-Chih ChangNashville$66K
- Karen WinkfieldNashville$53K
- James GrayNashville$46K
- David RobergeMemphis$28K
- Matthew BalloMemphis$25K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.